Cargando…
Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy
BACKGROUND: In vitro experiments have revealed that toll-like receptor 4 (TLR4) pathway is involved in the progression of immunoglobulin A nephropathy (IgAN) by induction of proinflammatory cytokines. Evidence showed that, in other disease models, peroxisome proliferator-activated receptor-γ (PPAR-γ...
Autores principales: | Zou, Jia-Nan, Xiao, Jing, Hu, Sha-Sha, Fu, Chen-Sheng, Zhang, Xiao-Li, Zhang, Zhen-Xing, Lu, Yi-Jun, Chen, Wei-Jun, Ye, Zhi-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407036/ https://www.ncbi.nlm.nih.gov/pubmed/28397719 http://dx.doi.org/10.4103/0366-6999.204101 |
Ejemplares similares
-
Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy
por: Chen, Xiaowen, et al.
Publicado: (2015) -
Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy
por: Shen, Yunzhu, et al.
Publicado: (2022) -
Anti-tumor Activity of Toll-Like Receptor 7 Agonists
por: Chi, Huju, et al.
Publicado: (2017) -
Association between Nod-like receptor protein 3 inflammasome and gouty nephropathy
por: Zhang, Yan-Zi, et al.
Publicado: (2020) -
Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
por: Rao, Ravi Prakash, et al.
Publicado: (2011)